Leerink Partners on OmniAb, Inc. (OABI): we see no change to OABI outlook from IMVT trial failure

Go back to Leerink Partners on OmniAb, Inc. (OABI): we see no change to OABI outlook from IMVT trial failure
(NASDAQ: OABI) Delayed: 3.38 -0.05 (1.46%)
Previous Close $3.43    52 Week High
Open $3.40    52 Week Low
Day High $3.45    P/E N/A 
Day Low $3.30    EPS
Volume 554,414